Respiratory Syncytial Virus and Other Vaccine-preventable Infections in Multiple Myeloma. A Population-based Study on 8,672 Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Overview

Journal Haematologica

Specialty Hematology

Date 2024 Jun 27

PMID 38934063

Authors

Sigrun Einarsdottir

Ingigerdur Sverrisdottir

Mariana Villegas-Scivetti

Chris Day

Ingemar Turesson

Gunnar Juliusson

Markus Hansson

Gunnar Larfors

Cecilie Hveding Blimark

Affiliations

Soon will be listed here.

References

Frerichs K, Bosman P, van Velzen J, Fraaij P, Koopmans M, Rimmelzwaan G . Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients. Haematologica. 2019; 105(6):e302-e306. PMC: 7271608. DOI: 10.3324/haematol.2019.231860. View

Raje N, Anaissie E, Kumar S, Lonial S, Martin T, Gertz M . Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Lancet Haematol. 2022; 9(2):e143-e161. DOI: 10.1016/S2352-3026(21)00283-0. View

Wiedmeier-Nutor J, Iqbal M, Rosenthal A, Bezerra E, Garcia-Robledo J, Bansal R . Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023; 23(6):456-462. PMC: 9990888. DOI: 10.1016/j.clml.2023.03.002. View

Mustafa S, Shah D, Bress J, Jamshed S . Response to PCV13 vaccination in patients with multiple myeloma versus healthy controls. Hum Vaccin Immunother. 2018; 15(2):452-454. PMC: 6422465. DOI: 10.1080/21645515.2018.1534516. View

Backhaus E, Berg S, Andersson R, Ockborn G, Malmstrom P, Dahl M . Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis. 2016; 16:367. PMC: 4972955. DOI: 10.1186/s12879-016-1648-2. View

Ludvigsson J, Andersson E, Ekbom A, Feychting M, Kim J, Reuterwall C . External review and validation of the Swedish national inpatient register. BMC Public Health. 2011; 11:450. PMC: 3142234. DOI: 10.1186/1471-2458-11-450. View

Noonan K, Rudraraju L, Ferguson A, Emerling A, Pasetti M, Huff C . Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses. Clin Cancer Res. 2012; 18(5):1426-34. PMC: 3640365. DOI: 10.1158/1078-0432.CCR-11-1221. View

Thompson M, Boccadoro M, Leleu X, Vela-Ojeda J, van Rhee F, Weisel K . Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients. Clin Lymphoma Myeloma Leuk. 2023; 23(3):e171-e181. DOI: 10.1016/j.clml.2022.12.003. View

Renaud L, Schraen S, Fouquet G, Guidez S, Demarquette H, Nudel M . Response to pneumococcal vaccination in multiple myeloma. Cancer Med. 2019; 8(8):3822-3830. PMC: 6639194. DOI: 10.1002/cam4.2253. View

10.

Harboe Z, Dalby T, Weinberger D, Benfield T, Molbak K, Slotved H . Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis. 2014; 59(8):1066-73. DOI: 10.1093/cid/ciu524. View

11.

Hoornaert E, Dachy F, Hansenne A, Bailly S, van Maanen A, Gruson D . COVID-19: impact of vaccination in myeloma patients. Ann Hematol. 2022; 101(7):1607-1608. PMC: 9001015. DOI: 10.1007/s00277-022-04799-7. View

12.

Ludwig H, Boccadoro M, Moreau P, San-Miguel J, Cavo M, Pawlyn C . Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia. 2020; 35(1):31-44. PMC: 7787974. DOI: 10.1038/s41375-020-01016-0. View

13.

Teh B, Worth L, Harrison S, Thursky K, Slavin M . Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital. Support Care Cancer. 2014; 23(7):1901-6. PMC: 7087950. DOI: 10.1007/s00520-014-2550-3. View

14.

Blimark C, Holmberg E, Mellqvist U, Landgren O, Bjorkholm M, Hultcrantz M . Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2014; 100(1):107-13. PMC: 4281323. DOI: 10.3324/haematol.2014.107714. View

15.

Blimark C, Juul Vangsted A, Klausen T, Gregersen H, Szabo A, Hermansen E . Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries. Eur J Haematol. 2021; 108(2):99-108. DOI: 10.1111/ejh.13707. View